Cargando…
A Prospective, Randomized, Placebo-Controlled Study of a Combination of Simvastatin and Chemotherapy in Metastatic Breast Cancer
Preclinical studies support the anticancer activity of statins; however, the existing clinical evidence is inconsistent and not definitive. Our study aimed at evaluating a postulated cancer chemo-sensitizing effect of statin (simvastatin) in a cohort of metastatic breast cancer (MBC) patients. We de...
Autores principales: | Alarfi, Hiba, Youssef, Lama A., Salamoon, Maher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436279/ https://www.ncbi.nlm.nih.gov/pubmed/32849871 http://dx.doi.org/10.1155/2020/4174395 |
Ejemplares similares
-
The impact of baseline body mass index on clinical outcomes in metastatic breast cancer: a prospective study
por: Alarfi, Hiba, et al.
Publicado: (2017) -
Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Villegas-Rivera, Geannyne, et al.
Publicado: (2015) -
A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
por: Lim, S H, et al.
Publicado: (2015) -
Metronomic Cyclophosphamide and Methotrexate Chemotherapy Combined with 1E10 Anti-Idiotype Vaccine in Metastatic Breast Cancer
por: Soriano, Jorge L., et al.
Publicado: (2011) -
The Role of Simvastatin in the Therapeutic Approach of Rheumatoid Arthritis
por: Cojocaru, Lucia, et al.
Publicado: (2013)